Chinese Journal of Integrative Medicine

, Volume 16, Issue 4, pp 331–336 | Cite as

Shenmai Injection (参麦注射液) inhibiting the extracellular signal regulated kinase-induced human airway smooth muscle proliferation in asthma

  • Li-min Zhao (赵丽敏)
  • Li-jun Ma (马利军)
  • Luo-xian Zhang (张罗献)
  • Ji-zhen Wu (吴纪珍)
Experimental Research



To investigate the relationship between the proliferation of sensitized human airway smooth muscle cells (HASMCs) and the expression of extracellular signal regulated kinase (ERK) and the effect of Shenmai Injection (参麦注射液, SMI) on HASMCs.


The HASMCs cultured in vitro were divided into three groups: (1) control group; (2) sensitized group: containing 10% asthmatic serum; (3) SMI group: further divided into three different concentration subgroups interferred with 10 μL/mL, 50 μL/mL, and 100 μL/mL SMI, respectively. The proliferation of HASMCs was detected using MTT method, the expression of proliferating cell nucleus antigen (PCNA) in HASMCs was detected using immunocytochemical staining, and the expression of phosphoration-ERK1/2 (p-ERK1/2) protein was detected using Western-blot.


After passive sensitization,: the optical density value (A A490 value) of HASMCs was significantly increased from 0.366±0.086 to 0.839± 0.168 (P<0.05). In addition, the expression of PCNA was significantly increased from 28.7%±5.9% in the control group to 69.8%±7.5% in the sensitized group (P<0.05). At the same time, the expression of p-ERK1/2 in passively sensitized HASMCs was significantly increased compared with the control group (all P<0.05). After application of 10 μL/mL, 50 μL/mL, and 100 μL/mL SMI to the cultured media of passively sensitized group, the A570 value was significantly decreased from 0.839±0.168 to 0.612±0.100, 0.412±0.092, and 0.339±0.077, respectively (P<0.05). Moreover, the expression of PCNA was significantly decreased from 69.8%±7.5% to 57.8%±6.2%, 40.7%±5.4%, and 26.1%±5.2%, respectively. At the same time, the expression of p-ERK1/2 in each SMI group was significantly decreased compared with the sensitized group (all P<0.05).


ERK signal transduction pathway may be involved in the airway remodeling in asthma. The expression of ERK can be inhibited by SMI in a dose-dependent manner, thus preventing the proliferation of HASMCs.


Shenmai Injection airway smooth muscle cells extracellular signal regulated kinase airway remodeling 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults. Chest 2004;125:1081–1102.CrossRefPubMedGoogle Scholar
  2. 2.
    Boxall C, Holgate ST, Davies DE. The contribution of transforming growth factor-beta and epidermal growth factor signalling to airway remodelling in chronic asthma. Eur Respir 2006;27:208–229.CrossRefGoogle Scholar
  3. 3.
    Covar RA, Cool C, Szefler SJ. Progression of asthma in childhood. J Allergy Clin Immunol 2005;115:700–707.CrossRefPubMedGoogle Scholar
  4. 4.
    Fredberg JJ. Bronchospasm and its biophysical basis in airway smooth muscle. Respir Res 2004;5:2–23.CrossRefPubMedGoogle Scholar
  5. 5.
    Fahy JV, Corry DB, Boushey HA. Airway inflammation and remodelling in asthma. Curr Opin Pulm Med 2000;6:15–20.CrossRefPubMedGoogle Scholar
  6. 6.
    Seow CY, Schellenberg RR, Pare PD. Structural and functional changes in the airway smooth muscle of asthmatic subjects. Am J Respir Crit Care Med 1998;158:S179–S186.PubMedGoogle Scholar
  7. 7.
    Rubinfeld H, Seger R. The ERK cascade: a prototype of MAPK signaling. Mol Biotechnol 2005;31:151–174.CrossRefPubMedGoogle Scholar
  8. 8.
    Davids RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993;268:14553–14556.Google Scholar
  9. 9.
    Guan XJ, Zhang WX, Su MS, Wang ZM, Li CC, Ye LP, et al. Role of ERK signal transduction pathway in rats airway remodelling. Chin J Immunol (Chin) 2007;11:1026–1030.Google Scholar
  10. 10.
    Laporte JC, Moore PE, Baraldo S, Jouvin MH, Church TL, Schwartzman IN, et al. Direct efforts of interleukin-13 on signaling pathways for physiological responses in cultured human airway smooth muscle cells. Am J Respir Crit Care Med 2001;164:141–148.PubMedGoogle Scholar
  11. 11.
    Johnson PR, Black JL, Carlin S, Ge Q, Underwood PA. The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone. Am J Respir Crit Care Med 2000;162:2145–2151.PubMedGoogle Scholar
  12. 12.
    Black JL, Johnson PR. What determines asthma phenotype? Is it the interaction between allergy and the smooth muscle? Am J Respir Crit Med 2000;161:207–210.Google Scholar
  13. 13.
    Xu SY, Xu YJ, Zhang ZX, Ni W, Chen SX. Contribution of protein kinase C to passively sensitized human airway smooth muscle cells proliferation. Chin Med J 2004;117:30–36.PubMedGoogle Scholar
  14. 14.
    Zhao LM, Xu YJ, Zhang ZX, Ni W, Chen SX. The effect of passive sensitization on the activity and expression of KV channel in human bronchial smooth muscle cells. Chin Med J 2004;11:1630–1636.Google Scholar
  15. 15.
    Niu RJ, Fu J, Liu HG. Effect of Shenmai Injection and aminophylline on small airway smooth muscle cell apoptosis and related gene expression in rats with emphysema. Chin J Integr Tradit West Med (Chin) 2002;22:40–42.Google Scholar
  16. 16.
    Zhao LM, Xiong SD, Niu RJ, Xu YJ. Effect of Shenmai Injection on L-type calcium current of diaphragmatic muscle in rats. Chin J Integr Tradit West Med (Chin) 2003;8:599–602.Google Scholar
  17. 17.
    Chinese Society of Respiratory Diseases, Chinese Medical Association. Guidelines for prevention and treatment of bronchial asthma. Chin J Tuberc Respir Dis (Chin) 2008;3:177–185.Google Scholar
  18. 18.
    Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 1997;9:180–186.CrossRefPubMedGoogle Scholar
  19. 19.
    Matthew PH, Lynm M, Dilys L, Hirst SJ. Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle. Am J Respir Crit Care Med 2001;164:688–697.Google Scholar
  20. 20.
    Force T, Bonventre JV. Growth factors and mitogenactivated protein kinases. Hypertension 1998;31:152–161.PubMedGoogle Scholar
  21. 21.
    Jung JR, Kim H, Jeun SS, Lee JY, Koh EJ, Ji C. The phosphorylation status of merlin is important for regulating the RES-ERK pathway. Mol Cells 2005; 20:196–200.PubMedGoogle Scholar
  22. 22.
    Bhagavathula N, Kelley EA, Reddy M, Suzuki N, Shimosegawa T. Endothelin-1 stimulates contraction and migration of rat pancreatic stellate cells. World J Gastroenterol 2005;11:6144–6151.Google Scholar
  23. 23.
    Zhao YL, Liu J, Li L, Liu L, Wu L. Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation. Regul Pept 2005;128:43–50.CrossRefPubMedGoogle Scholar
  24. 24.
    Cui JJ, Zhu YJ, Wu MD. Application of Shenmai Injection in clinic. China Pharmacist (Chin) 2004;7:305–307.Google Scholar
  25. 25.
    Ye DJ, Wu P, Niu RJ. Experimental study on effect of Shenmai Injection in improving contractility of fatigue diaphragm in rats. Chin J Integr Tradit West Med (Chin) 2000;20:679–681.Google Scholar
  26. 26.
    Wang C, Hu G, Liu Y, Zhou Q, Shao G, Li YL. Influence of ginsenosides on contractility of fatigued diaphragm in rats. J Bengbu Med Coll (Chin) 2005;30:121–123.Google Scholar
  27. 27.
    Zhang LJ, Zhang WJ, He LH. Study on effect of Shenmai Injection on immunologic function of patients with bronchial asthma. J Liaoning Coll Tradit Chin Med (Chin) 2006;8(3):79.Google Scholar
  28. 28.
    Luo YN, Niu RJ, Liu XS, Xu YJ. Effect of Shenmai Injection on the activity of calcium channels in airway smooth muscle cells of rat model with asthma. J Intern Intensive Med (Chin) 2008;14:300–302.Google Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2010

Authors and Affiliations

  • Li-min Zhao (赵丽敏)
    • 1
  • Li-jun Ma (马利军)
    • 1
  • Luo-xian Zhang (张罗献)
    • 1
  • Ji-zhen Wu (吴纪珍)
    • 1
  1. 1.Department of Respiratory DiseasesHenan Province People’s HospitalZhengzhouChina

Personalised recommendations